{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T04:11:58Z","timestamp":1745986318844,"version":"3.40.4"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203390","82203204","82072788"],"award-info":[{"award-number":["82203390","82203204","82072788"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["22140900200"],"award-info":[{"award-number":["22140900200"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s11060-025-04966-6","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T11:39:01Z","timestamp":1740742741000},"page":"105-119","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Establishment and transcriptomic characteristics of radio-resistant meningioma cell lines"],"prefix":"10.1007","volume":"173","author":[{"given":"Jinxiu","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leihao","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianqi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingyang","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daijun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaojiao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"key":"4966_CR1","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/noac202","volume":"24","author":"QT Ostrom","year":"2022","unstructured":"Ostrom QT, Price M, Neff C, Cioffi G, Waite KA, Kruchko C, Barnholtz-Sloan JS (2022) CBTRUS Statistical Report: primary brain and other Central Nervous System tumors diagnosed in the United States in 2015\u20132019. Neurooncology 24:v1\u2013v95. https:\/\/doi.org\/10.1093\/neuonc\/noac202","journal-title":"Neurooncology"},{"key":"4966_CR2","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1001\/jama.297.11.1207","volume":"297","author":"N Hijiya","year":"2007","unstructured":"Hijiya N, Hudson MM, Lensing S, Zacher M, Onciu M, Behm FG, Razzouk BI, Ribeiro RC, Rubnitz JE, Sandlund JT, Rivera GK, Evans WE, Relling MV, Pui CH (2007) Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia. JAMA 297:1207\u20131215. https:\/\/doi.org\/10.1001\/jama.297.11.1207","journal-title":"JAMA"},{"key":"4966_CR3","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/jnci\/94.20.1555","volume":"94","author":"DL Preston","year":"2002","unstructured":"Preston DL, Ron E, Yonehara S, Kobuke T, Fujii H, Kishikawa M, Tokunaga M, Tokuoka S, Mabuchi K (2002) Tumors of the nervous system and pituitary gland associated with atomic bomb radiation exposure. J Natl Cancer Inst 94:1555\u20131563. https:\/\/doi.org\/10.1093\/jnci\/94.20.1555","journal-title":"J Natl Cancer Inst"},{"key":"4966_CR4","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s11060-010-0386-3","volume":"99","author":"J Wiemels","year":"2010","unstructured":"Wiemels J, Wrensch M, Claus EB (2010) Epidemiology and etiology of meningioma. J Neurooncol 99:307\u2013314. https:\/\/doi.org\/10.1007\/s11060-010-0386-3","journal-title":"J Neurooncol"},{"key":"4966_CR5","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/cncr.22783","volume":"110","author":"EB Claus","year":"2007","unstructured":"Claus EB, Black PM, Bondy ML, Calvocoressi L, Schildkraut JM, Wiemels JL, Wrensch M (2007) Exogenous hormone use and meningioma risk: what do we tell our patients? Cancer 110:471\u2013476. https:\/\/doi.org\/10.1002\/cncr.22783","journal-title":"Cancer"},{"key":"4966_CR6","doi-asserted-by":"publisher","first-page":"920","DOI":"10.3171\/2009.8.JNS09201","volume":"112","author":"S Vadivelu","year":"2010","unstructured":"Vadivelu S, Sharer L, Schulder M (2010) Regression of multiple intracranial meningiomas after cessation of long-term progesterone agonist therapy. J Neurosurg 112:920\u2013924. https:\/\/doi.org\/10.3171\/2009.8.JNS09201","journal-title":"J Neurosurg"},{"key":"4966_CR7","doi-asserted-by":"publisher","first-page":"756","DOI":"10.25259\/JNRP_305_2023","volume":"14","author":"A Patnaik","year":"2023","unstructured":"Patnaik A, Pattnaik N, Sekar A, Singh DK (2023) Meningioma getting a common presentation in uncommon Cowden syndrome: a case report. J Neurosci Rural Pract 14:756\u2013758. https:\/\/doi.org\/10.25259\/JNRP_305_2023","journal-title":"J Neurosci Rural Pract"},{"key":"4966_CR8","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/BF00225206","volume":"95","author":"L Papi","year":"1995","unstructured":"Papi L, De Vitis LR, Vitelli F, Ammannati F, Mennonna P, Montali E, Bigozzi U (1995) Somatic mutations in the neurofibromatosis type 2 gene in sporadic meningiomas. Hum Genet 95:347\u2013351. https:\/\/doi.org\/10.1007\/BF00225206","journal-title":"Hum Genet"},{"key":"4966_CR9","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1093\/neuonc\/noab150","volume":"23","author":"R Goldbrunner","year":"2021","unstructured":"Goldbrunner R, Stavrinou P, Jenkinson MD, Sahm F, Mawrin C, Weber DC, Preusser M, Minniti G, Lund-Johansen M, Lefranc F, Houdart E, Sallabanda K, Le Rhun E, Nieuwenhuizen D, Tabatabai G, Soffietti R, Weller M (2021) EANO guideline on the diagnosis and management of meningiomas. Neurooncology 23:1821\u20131834. https:\/\/doi.org\/10.1093\/neuonc\/noab150","journal-title":"Neurooncology"},{"issue":"5","key":"4966_CR10","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1093\/neuros\/nyaa169","volume":"87","author":"M Marchetti","year":"2020","unstructured":"Marchetti M, Sahgal A, De Salles AAF, Levivier M, Ma L, Paddick I, Pollock BE, Regis J, Sheehan J, Suh JH, Yomo S, Fariselli L (2020) Stereotactic radiosurgery for Intracranial Noncavernous Sinus Benign Meningioma: International Stereotactic Radiosurgery Society Systematic Review, Meta-Analysis and Practice Guideline. Neurosurgery 87(5):879\u2013890. https:\/\/doi.org\/10.1093\/neuros\/nyaa169","journal-title":"Neurosurgery"},{"key":"4966_CR11","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3171\/2014.12.JNS141341","volume":"124","author":"G Harrison","year":"2016","unstructured":"Harrison G, Kano H, Lunsford LD, Flickinger JC, Kondziolka D (2016) Quantitative tumor volumetric responses after Gamma Knife radiosurgery for meningiomas. J Neurosurg 124:146\u2013154. https:\/\/doi.org\/10.3171\/2014.12.JNS141341","journal-title":"J Neurosurg"},{"key":"4966_CR12","doi-asserted-by":"publisher","first-page":"e141","DOI":"10.1016\/j.wneu.2021.06.080","volume":"153","author":"JT Hall","year":"2021","unstructured":"Hall JT, Opalak CF, Carr MT, Harris TJ, Broaddus WC (2021) The Effect of Radiation on Meningioma volume change. World Neurosurg 153:e141\u2013e146. https:\/\/doi.org\/10.1016\/j.wneu.2021.06.080","journal-title":"World Neurosurg"},{"key":"4966_CR13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.adro.2018.08.013","volume":"4","author":"KR Fega","year":"2019","unstructured":"Fega KR, Fletcher GP, Waddle MR, Peterson JL, Ashman JB, Barrs DM, Bendok BR, Patel NP, Porter AB, Vora SA (2019) Analysis of MRI volumetric changes after Hypofractionated Stereotactic Radiation Therapy for Benign Intracranial neoplasms. Adv Radiation Oncol 4:43\u201349. https:\/\/doi.org\/10.1016\/j.adro.2018.08.013","journal-title":"Adv Radiation Oncol"},{"key":"4966_CR14","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s11060-018-2813-9","volume":"138","author":"WC Chen","year":"2018","unstructured":"Chen WC, Hara J, Magill ST, Wu A, Aghi MK, Theodosopoulos PV, Perry A, McDermott MW, Sneed PK, Raleigh DR, Braunstein SE (2018) Salvage therapy outcomes for atypical meningioma. J Neurooncol 138:425\u2013433. https:\/\/doi.org\/10.1007\/s11060-018-2813-9","journal-title":"J Neurooncol"},{"key":"4966_CR15","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1227\/NEU.0b013e3181f2f427","volume":"67","author":"CY Choi","year":"2010","unstructured":"Choi CY, Soltys SG, Gibbs IC, Harsh GR, Jackson PS, Lieberson RE, Chang SD, Adler JR (2010) Cyberknife stereotactic radiosurgery for treatment of atypical (WHO grade II) cranial meningiomas. Neurosurgery 67:1180\u20131188. https:\/\/doi.org\/10.1227\/NEU.0b013e3181f2f427","journal-title":"Neurosurgery"},{"key":"4966_CR16","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1002\/cncr.26362","volume":"118","author":"BE Pollock","year":"2012","unstructured":"Pollock BE, Stafford SL, Link MJ, Garces YI, Foote RL (2012) Stereotactic radiosurgery of World Health Organization grade II and III intracranial meningiomas: treatment results on the basis of a 22-year experience. Cancer 118:1048\u20131054. https:\/\/doi.org\/10.1002\/cncr.26362","journal-title":"Cancer"},{"key":"4966_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11060-007-9338-y","volume":"84","author":"H Kano","year":"2007","unstructured":"Kano H, Takahashi JA, Katsuki T, Araki N, Oya N, Hiraoka M, Hashimoto N (2007) Stereotactic radiosurgery for atypical and anaplastic meningiomas. J Neurooncol 84:41\u201347. https:\/\/doi.org\/10.1007\/s11060-007-9338-y","journal-title":"J Neurooncol"},{"key":"4966_CR18","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.3171\/2014.9.Jns14233","volume":"122","author":"R Aboukais","year":"2015","unstructured":"Aboukais R, Zairi F, Lejeune JP, Le Rhun E, Vermandel M, Blond S, Devos P, Reyns N (2015) Grade 2 meningioma and radiosurgery. J Neurosurg 122:1157\u20131162. https:\/\/doi.org\/10.3171\/2014.9.Jns14233","journal-title":"J Neurosurg"},{"key":"4966_CR19","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.ijrobp.2007.12.020","volume":"71","author":"D Pasquier","year":"2008","unstructured":"Pasquier D, Bijmolt S, Veninga T, Rezvoy N, Villa S, Krengli M, Weber DC, Baumert BG, Canyilmaz E, Yalman D, Szutowicz E, Tzuk-Shina T, Mirimanoff RO, Rare Cancer N (2008) Atypical and malignant meningioma: outcome and prognostic factors in 119 irradiated patients. A multicenter, retrospective study of the Rare Cancer Network. Int J Radiat Oncol Biol Phys 71:1388\u20131393. https:\/\/doi.org\/10.1016\/j.ijrobp.2007.12.020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4966_CR20","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1023\/a:1006434124794","volume":"48","author":"EB Hug","year":"2000","unstructured":"Hug EB, Devries A, Thornton AF, Munzenride JE, Pardo FS, Hedley-Whyte ET, Bussiere MR, Ojemann R (2000) Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy. J Neurooncol 48:151\u2013160. https:\/\/doi.org\/10.1023\/a:1006434124794","journal-title":"J Neurooncol"},{"key":"4966_CR21","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s11060-021-03711-z","volume":"152","author":"AA Momin","year":"2021","unstructured":"Momin AA, Shao J, Soni P, Almeida JP, Suh JH, Murphy ES, Chao ST, Angelov L, Mohammadi AM, Barnett GH, Recinos PF, Kshettry VR (2021) Outcomes of salvage radiation for recurrent world health organization grade II meningiomas: a retrospective cohort study. J Neurooncol 152:373\u2013382. https:\/\/doi.org\/10.1007\/s11060-021-03711-z","journal-title":"J Neurooncol"},{"key":"4966_CR22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/neuonc\/noac137","volume":"25","author":"CL Rogers","year":"2023","unstructured":"Rogers CL, Pugh SL, Vogelbaum MA, Perry A, Ashby LS, Modi JM, Alleman AM, Barani IJ, Braunstein S, Bovi JA, de Groot JF, Whitton AC, Lindhorst SM, Deb N, Shrieve DC, Shu HK, Bloom B, Machtay M, Mishra MV, Robinson CG, Won M, Mehta MP (2023) Low-risk meningioma: initial outcomes from NRG Oncology\/RTOG 0539. Neurooncology 25:137\u2013145. https:\/\/doi.org\/10.1093\/neuonc\/noac137","journal-title":"Neurooncology"},{"key":"4966_CR23","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/0360-3016(95)02166-3","volume":"34","author":"MF Milosevic","year":"1996","unstructured":"Milosevic MF, Frost PJ, Laperriere NJ, Wong CS, Simpson WJ (1996) Radiotherapy for atypical or malignant intracranial meningioma. Int J Radiat Oncol Biol Phys 34:817\u2013822. https:\/\/doi.org\/10.1016\/0360-3016(95)02166-3","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4966_CR24","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41392-020-0150-x","volume":"5","author":"RX Huang","year":"2020","unstructured":"Huang RX, Zhou PK (2020) DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer. Signal Transduct Target Ther 5:60. https:\/\/doi.org\/10.1038\/s41392-020-0150-x","journal-title":"Signal Transduct Target Ther"},{"key":"4966_CR25","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.radonc.2011.05.044","volume":"99","author":"J Theys","year":"2011","unstructured":"Theys J, Jutten B, Habets R, Paesmans K, Groot AJ, Lambin P, Wouters BG, Lammering G, Vooijs M (2011) E-Cadherin loss associated with EMT promotes radioresistance in human tumor cells. Radiotherapy Oncology: J Eur Soc Therapeutic Radiol Oncol 99:392\u2013397. https:\/\/doi.org\/10.1016\/j.radonc.2011.05.044","journal-title":"Radiotherapy Oncology: J Eur Soc Therapeutic Radiol Oncol"},{"key":"4966_CR26","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.ijrobp.2004.03.005","volume":"59","author":"TM Pawlik","year":"2004","unstructured":"Pawlik TM, Keyomarsi K (2004) Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol Biol Phys 59:928\u2013942. https:\/\/doi.org\/10.1016\/j.ijrobp.2004.03.005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4966_CR27","doi-asserted-by":"publisher","first-page":"103452","DOI":"10.1016\/j.redox.2024.103452","volume":"79","author":"B Alkotub","year":"2024","unstructured":"Alkotub B, Bauer L, Bashiri Dezfouli A, Hachani K, Ntziachristos V, Multhoff G, Kafshgari MH (2024) Radiosensitizing capacity of fenofibrate in glioblastoma cells depends on lipid metabolism. Redox Biol 79:103452. https:\/\/doi.org\/10.1016\/j.redox.2024.103452","journal-title":"Redox Biol"},{"key":"4966_CR28","doi-asserted-by":"publisher","unstructured":"Pasqualetti F, Miniati M, Gonnelli A, Gadducci G, Giannini N, Palagini L, Mancino M, Fuentes T, Paiar F (2023) Cancer Stem cells and Glioblastoma: time for innovative biomarkers of Radio-Resistance? Biology (Basel) 12. https:\/\/doi.org\/10.3390\/biology12101295","DOI":"10.3390\/biology12101295"},{"key":"4966_CR29","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nrc2397","volume":"8","author":"MW Dewhirst","year":"2008","unstructured":"Dewhirst MW, Cao Y, Moeller B (2008) Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response. Nat Rev Cancer 8:425\u2013437. https:\/\/doi.org\/10.1038\/nrc2397","journal-title":"Nat Rev Cancer"},{"key":"4966_CR30","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12964-024-01541-w","volume":"22","author":"X Dai","year":"2024","unstructured":"Dai X, Wu Z, Ruan R, Chen J, Huang C, Lei W, Yao Y, Li L, Tang X, Xiong J, Feng M, Deng J (2024) TMEM160 promotes tumor immune evasion and radiotherapy resistance via PD-L1 binding in colorectal cancer. Cell Commun Signal 22:168. https:\/\/doi.org\/10.1186\/s12964-024-01541-w","journal-title":"Cell Commun Signal"},{"key":"4966_CR31","doi-asserted-by":"publisher","unstructured":"Macedo-Silva C, Miranda-Goncalves V, Henrique R, Jeronimo C, Bravo I (2019) The critical role of Hypoxic Microenvironment and Epigenetic Deregulation in Esophageal Cancer Radioresistance. Genes (Basel) 10. https:\/\/doi.org\/10.3390\/genes10110927","DOI":"10.3390\/genes10110927"},{"key":"4966_CR32","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1007\/s00432-014-1840-y","volume":"141","author":"D Nantajit","year":"2015","unstructured":"Nantajit D, Lin D, Li JJ (2015) The network of epithelial-mesenchymal transition: potential new targets for tumor resistance. J Cancer Res Clin Oncol 141:1697\u20131713. https:\/\/doi.org\/10.1007\/s00432-014-1840-y","journal-title":"J Cancer Res Clin Oncol"},{"key":"4966_CR33","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/1476-4598-12-94","volume":"12","author":"R Gomez-Casal","year":"2013","unstructured":"Gomez-Casal R, Bhattacharya C, Ganesh N, Bailey L, Basse P, Gibson M, Epperly M, Levina V (2013) Non-small cell lung cancer cells survived ionizing radiation treatment display cancer stem cell and epithelial-mesenchymal transition phenotypes. Mol Cancer 12:94. https:\/\/doi.org\/10.1186\/1476-4598-12-94","journal-title":"Mol Cancer"},{"key":"4966_CR34","doi-asserted-by":"publisher","first-page":"939","DOI":"10.3760\/cma.j.issn.0376-2491.2018.12.013","volume":"98","author":"YH Jiang","year":"2018","unstructured":"Jiang YH, You KY, Bi ZF, Li LT, Mo HQ, Liu YM (2018) [The relationship between the radioresistance of pancreatic cancer cell SW1990 and the induction of the epithelial-mesenchymal transition: an in vitro study]. Zhonghua Yi Xue Za Zhi 98:939\u2013943. https:\/\/doi.org\/10.3760\/cma.j.issn.0376-2491.2018.12.013","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"4966_CR35","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1038\/1991158a0","volume":"199","author":"WK Sinclair","year":"1963","unstructured":"Sinclair WK, Morton RA (1963) Variations in X-Ray response during the Division cycle of partially synchronized Chinese Hamster cells in culture. Nature 199:1158\u20131160. https:\/\/doi.org\/10.1038\/1991158a0","journal-title":"Nature"},{"key":"4966_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0006-3495(65)86700-5","volume":"5","author":"WK Sinclair","year":"1965","unstructured":"Sinclair WK, Morton RA (1965) X-Ray and Ultraviolet sensitivity of synchronized Chinese Hamster cells at various stages of the cell cycle. Biophys J 5:1\u201325. https:\/\/doi.org\/10.1016\/s0006-3495(65)86700-5","journal-title":"Biophys J"},{"key":"4966_CR37","doi-asserted-by":"publisher","first-page":"450","DOI":"10.2307\/3572025","volume":"29","author":"WK Sinclair","year":"1966","unstructured":"Sinclair WK, Morton RA (1966) X-ray sensitivity during the cell generation cycle of cultured Chinese hamster cells. Radiat Res 29:450\u2013474","journal-title":"Radiat Res"},{"key":"4966_CR38","doi-asserted-by":"publisher","first-page":"620","DOI":"10.2307\/3572419","volume":"33","author":"WK Sinclair","year":"1968","unstructured":"Sinclair WK (1968) Cyclic x-ray responses in mammalian cells in vitro. Radiat Res 33:620\u2013643","journal-title":"Radiat Res"},{"key":"4966_CR39","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1007\/s00432-017-2427-1","volume":"143","author":"SA Wieczorek","year":"2017","unstructured":"Wieczorek SA, Breitenbuecher F, Soni A, Paul-Konietzko K, Ziegler S, Sak A, Iliakis G, Schuler M (2017) Deregulated BCL-2 family proteins impact on repair of DNA double-strand breaks and are targets to overcome radioresistance in lung cancer. J Cancer Res Clin Oncol 143:1733\u20131744. https:\/\/doi.org\/10.1007\/s00432-017-2427-1","journal-title":"J Cancer Res Clin Oncol"},{"key":"4966_CR40","doi-asserted-by":"publisher","unstructured":"Sobol B, Azzam Nieto O, Eberlein EL, Scherr AL, Ismail L, Kessler A, Nader L, Schwab M, Hoffmeister P, Schmitt N, Jager D, Welte S, Seidensaal K, Christopoulos P, Heilig C, Kriegsmann K, Frohling S, Kriegsmann M, Hess J, Kohler BC (2022) Specific Targeting of Antiapoptotic Bcl-2 Proteins as a Radiosensitizing Approach in Solid Tumors. International journal of molecular sciences 23 https:\/\/doi.org\/10.3390\/ijms23147850","DOI":"10.3390\/ijms23147850"},{"key":"4966_CR41","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.cpt.2022.09.001","volume":"1","author":"H Deng","year":"2023","unstructured":"Deng H, Chen Y, Li P, Hang Q, Zhang P, Jin Y, Chen M (2023) PI3K\/AKT\/mTOR pathway, hypoxia, and glucose metabolism: potential targets to overcome radioresistance in small cell lung cancer. Cancer Pathog Ther 1:56\u201366. https:\/\/doi.org\/10.1016\/j.cpt.2022.09.001","journal-title":"Cancer Pathog Ther"},{"key":"4966_CR42","doi-asserted-by":"publisher","unstructured":"Su YC, Lee WC, Wang CC, Yeh SA, Chen WH, Chen PJ (2022) Targeting PI3K\/AKT\/mTOR Signaling Pathway as a Radiosensitization in Head and Neck Squamous Cell Carcinomas. International journal of molecular sciences 23 https:\/\/doi.org\/10.3390\/ijms232415749","DOI":"10.3390\/ijms232415749"},{"key":"4966_CR43","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.canlet.2012.11.019","volume":"341","author":"DT Marie-Egyptienne","year":"2013","unstructured":"Marie-Egyptienne DT, Lohse I, Hill RP (2013) Cancer stem cells, the epithelial to mesenchymal transition (EMT) and radioresistance: potential role of hypoxia. Cancer Lett 341:63\u201372. https:\/\/doi.org\/10.1016\/j.canlet.2012.11.019","journal-title":"Cancer Lett"},{"key":"4966_CR44","doi-asserted-by":"publisher","unstructured":"Xu Z, Zhang Y, Dai H, Han B (2022) Epithelial-mesenchymal transition-mediated Tumor Therapeutic Resistance. Molecules 27. https:\/\/doi.org\/10.3390\/molecules27154750","DOI":"10.3390\/molecules27154750"},{"key":"4966_CR45","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s13046-023-02789-9","volume":"42","author":"T Liu","year":"2023","unstructured":"Liu T, Wang H, Chen Y, Wan Z, Du Z, Shen H, Yu Y, Ma S, Xu Y, Li Z, Yu N, Zhang F, Cao K, Cai J, Zhang W, Gao F, Yang Y (2023) SENP5 promotes homologous recombination-mediated DNA damage repair in colorectal cancer cells through H2AZ deSUMOylation. J Experimental Clin cancer Research: CR 42:234. https:\/\/doi.org\/10.1186\/s13046-023-02789-9","journal-title":"J Experimental Clin cancer Research: CR"},{"key":"4966_CR46","doi-asserted-by":"publisher","first-page":"e785","DOI":"10.1002\/ctm2.785","volume":"12","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Zhang Y, Peng C, Li Z, Pei H, Pei H, Zhu W (2022) And-1 O-GlcNAcylation regulates homologous recombination repair and radioresistance in colorectal cancer. Clin Transl Med 12:e785. https:\/\/doi.org\/10.1002\/ctm2.785","journal-title":"Clin Transl Med"},{"key":"4966_CR47","doi-asserted-by":"publisher","first-page":"216440","DOI":"10.1016\/j.canlet.2023.216440","volume":"577","author":"X Zhao","year":"2023","unstructured":"Zhao X, Ma Y, Li J, Sun X, Sun Y, Qu F, Shi X, Xie Y, Liu S, Ma Y, Ji C, Hu W, Che S, Zhang X (2023) The AEG-1-USP10-PARP1 axis confers radioresistance in esophageal squamous cell carcinoma via facilitating homologous recombination-dependent DNA damage repair. Cancer Lett 577:216440. https:\/\/doi.org\/10.1016\/j.canlet.2023.216440","journal-title":"Cancer Lett"},{"key":"4966_CR48","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/s41418-024-01287-5","volume":"31","author":"P Feng","year":"2024","unstructured":"Feng P, Wang Y, Liu N, Chen Y, Hu Y, Huang Z, Liu Y, Zheng S, Jiang T, Xiao X, Dai W, Huang P, Xia Y (2024) High expression of PPP1CC promotes NHEJ-mediated DNA repair leading to radioresistance and poor prognosis in nasopharyngeal carcinoma. Cell Death Differ 31:683\u2013696. https:\/\/doi.org\/10.1038\/s41418-024-01287-5","journal-title":"Cell Death Differ"},{"key":"4966_CR49","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41419-024-06651-4","volume":"15","author":"J Tian","year":"2024","unstructured":"Tian J, Wen M, Gao P, Feng M, Wei G (2024) RUVBL1 ubiquitination by DTL promotes RUVBL1\/2-beta-catenin-mediated transcriptional regulation of NHEJ pathway and enhances radiation resistance in breast cancer. Cell Death Dis 15:259. https:\/\/doi.org\/10.1038\/s41419-024-06651-4","journal-title":"Cell Death Dis"},{"key":"4966_CR50","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/s00018-024-05469-9","volume":"81","author":"D Sarkar","year":"2024","unstructured":"Sarkar D, Chakraborty A, Mandi S, Dutt S (2024) PARylation of GCN5 by PARP1 mediates its recruitment to DSBs and facilitates both HR and NHEJ Repair. Cell Mol Life Sci 81:446. https:\/\/doi.org\/10.1007\/s00018-024-05469-9","journal-title":"Cell Mol Life Sci"},{"key":"4966_CR51","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40170-023-00304-4","volume":"11","author":"FV Reinema","year":"2023","unstructured":"Reinema FV, Sweep F, Adema GJ, Peeters WJM, Martens JWM, Bussink J, Span PN (2023) Tamoxifen induces radioresistance through NRF2-mediated metabolic reprogramming in breast cancer. Cancer Metab 11:3. https:\/\/doi.org\/10.1186\/s40170-023-00304-4","journal-title":"Cancer Metab"},{"key":"4966_CR52","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13046-019-1214-z","volume":"38","author":"J Lin","year":"2019","unstructured":"Lin J, Xia L, Liang J, Han Y, Wang H, Oyang L, Tan S, Tian Y, Rao S, Chen X, Tang Y, Su M, Luo X, Wang Y, Wang H, Zhou Y, Liao Q (2019) The roles of glucose metabolic reprogramming in chemo- and radio-resistance. J Experimental Clin cancer Research: CR 38:218. https:\/\/doi.org\/10.1186\/s13046-019-1214-z","journal-title":"J Experimental Clin cancer Research: CR"},{"key":"4966_CR53","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s40164-024-00519-1","volume":"13","author":"Z Shi","year":"2024","unstructured":"Shi Z, Hu C, Zheng X, Sun C, Li Q (2024) Feedback loop between hypoxia and energy metabolic reprogramming aggravates the radioresistance of cancer cells. Experimental Hematol Oncol 13:55. https:\/\/doi.org\/10.1186\/s40164-024-00519-1","journal-title":"Experimental Hematol Oncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-04966-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-025-04966-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-04966-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T08:30:14Z","timestamp":1745915414000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-025-04966-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["4966"],"URL":"https:\/\/doi.org\/10.1007\/s11060-025-04966-6","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"type":"print","value":"0167-594X"},{"type":"electronic","value":"1573-7373"}],"subject":[],"published":{"date-parts":[[2025,2,28]]},"assertion":[{"value":"16 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}